Seth M Cohen1, Jaewhan Kim, Nelson Roy, Mark Courey. 1. Duke Voice Care Center, Division of Otolaryngology-Head and Neck Surgery, Duke University Medical Center, Durham, North Carolina, USA. seth.cohen@duke.edu
Abstract
OBJECTIVES/HYPOTHESIS: To examine how age, gender, comorbidity, geography, provider type, and laryngeal pathology influence the use of pharmacological treatment in managing patients with laryngeal disorders. STUDY DESIGN: Retrospective analysis of data from a large, nationally representative, administrative, US claims database. METHODS: Patients with a laryngeal disorder based on International Classification of Diseases, Ninth Revision, Clinical Modification codes from January 1, 2004 to December 31, 2008, seen as an outpatient by a primary care physician (PCP), otolaryngologist, or both and continuously enrolled for 12 months were included. Data regarding pharmacy claims, age, gender, geographic location, comorbid conditions, provider type, and laryngeal diagnosis were collected. To identify factors that influenced whether a patient received a medication or not, a logistic regression was performed. RESULTS: Of almost 55 million individuals in the database, 258,705 had a laryngeal diagnosis 12 months post-index date follow-up and an outpatient encounter with a PCP, otolaryngologist, or both. A total of 135,973 (52.6%) unique patients, mean age 47.4 years (22.2 standard deviation [SD]), with 61.9% female, received a medication, and 122,732 (47.4%), mean age 47.4 years (19.8 SD), with 65.8% female, did not. Higher odds ratios for medication treatment were associated with PCPs versus otolaryngologists, acute laryngitis, the South region, and patients with comorbid conditions. Variable prescription patterns were also observed for age and gender. CONCLUSIONS: Multiple factors are associated with the use of medical treatment for laryngeal disorders.
OBJECTIVES/HYPOTHESIS: To examine how age, gender, comorbidity, geography, provider type, and laryngeal pathology influence the use of pharmacological treatment in managing patients with laryngeal disorders. STUDY DESIGN: Retrospective analysis of data from a large, nationally representative, administrative, US claims database. METHODS:Patients with a laryngeal disorder based on International Classification of Diseases, Ninth Revision, Clinical Modification codes from January 1, 2004 to December 31, 2008, seen as an outpatient by a primary care physician (PCP), otolaryngologist, or both and continuously enrolled for 12 months were included. Data regarding pharmacy claims, age, gender, geographic location, comorbid conditions, provider type, and laryngeal diagnosis were collected. To identify factors that influenced whether a patient received a medication or not, a logistic regression was performed. RESULTS: Of almost 55 million individuals in the database, 258,705 had a laryngeal diagnosis 12 months post-index date follow-up and an outpatient encounter with a PCP, otolaryngologist, or both. A total of 135,973 (52.6%) unique patients, mean age 47.4 years (22.2 standard deviation [SD]), with 61.9% female, received a medication, and 122,732 (47.4%), mean age 47.4 years (19.8 SD), with 65.8% female, did not. Higher odds ratios for medication treatment were associated with PCPs versus otolaryngologists, acute laryngitis, the South region, and patients with comorbid conditions. Variable prescription patterns were also observed for age and gender. CONCLUSIONS: Multiple factors are associated with the use of medical treatment for laryngeal disorders.
Authors: Tasneem F Ahmed; Farah Khandwala; Tom I Abelson; Douglas M Hicks; Joel E Richter; Claudio Milstein; Michael F Vaezi Journal: Am J Gastroenterol Date: 2006-03 Impact factor: 10.864
Authors: Seth M Cohen; Hui-Jie Lee; David A Leiman; Nelson Roy; Stephanie Misono Journal: Otolaryngol Head Neck Surg Date: 2018-11-13 Impact factor: 3.497
Authors: Marie E Jetté; Eric A Gaumnitz; Martin A Birchall; Nathan V Welham; Susan L Thibeault Journal: Laryngoscope Date: 2014-05-27 Impact factor: 3.325